Skip to search formSkip to main contentSkip to account menu

17-monochloroacetylajmaline

Known as: chloroacetylajmaline 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Ajmaline
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
1980
[Agranulocytosis induced by chloroacetylajmaline (author's transl)].
1980
1980
Antiarrhythmic and cardiovascular properties of 17-monochloroacetylajmaline (17-MCAA).
1979
1979
[Agranulocytosis during a treatment by the chloroacetylajmaline].
1977
1977
[Chloroacetylajmaline-induced agranulocytosis. 3 cases].
1977
1977
In vitro and in vivo observations on the erythrocyte uptake of 17-monochloroacetylajmaline.
The in vitro and in vivo observations on the uptake rate of 17-monochloroacetylajmaline by human erythrocytes showed that about… 
1975
1975
Determination of 17-monochloroacetylajmaline and its metabolite in plasma by TLC fluorescence detection.
A sensitive and specific method is described for the determination of 17-monochloroacetylajmaline (I) and its metabolite… 
1974
1974
[Preliminary clinical studies on the antiparkinson effects of 17-monochloroacetylajmaline].
1973
1973
Cardiac actions of 17-monochloroacetylajmaline, N-propylajmaline and ajmaline as studied in the heart-lung preparatins of the dog.
1973
1973
[Anti-arrhythmic activity of 17-monochloroacetylajmaline as compared with that of 17-21-dichloroacetylajmaline. Experimental and clinical study].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)